N4 Pharma PLC Strategic Asset Allocation Index
N4 Pharma PLC strategic asset allocation index. N4 Pharma PLC (N4P) has a Strategic Asset Allocation Index of 29.0% as of December 2016. Strategic assets (PP&E of GBX- plus long-term investments of GBX302.00K) total GBX302.00K, measured against net assets of GBX1.04 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See net asset quality index of N4 Pharma PLC to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Strategic Asset Allocation Index of N4 Pharma PLC (2004–2016)
Strategic asset allocation index of N4 Pharma PLC from 2004 to 2016. This chart shows how N4 Pharma PLC's Strategic Asset Allocation Index has evolved across 13 annual periods from 2004 to 2016. As of December 2016, the index stands at 29.0%, representing strategic assets of GBX302.00K against net assets of GBX1.04 Million GBX. Check tangible net worth ratio of N4 Pharma PLC to evaluate the tangible quality of the company's equity base.
N4 Pharma PLC Strategic Asset Allocation Index by Year (2004–2016)
N4 Pharma PLC strategic asset allocation index by year from 2004 to 2016. The table below presents the year-by-year Strategic Asset Allocation Index for N4 Pharma PLC from 2004 to 2016, covering 13 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see market value of N4 Pharma PLC.
| Year | SAAI | Strategic Assets (GBX) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2016 | 29.0% | GBX302.00K | GBX- | GBX302.00K | GBX1.04 Million | ▲ +21.2 pp |
| 2015 | 7.8% | GBX50.00K | GBX- | GBX50.00K | GBX641.00K | ▼ -51.3 pp |
| 2014 | 59.1% | GBX616.00K | GBX616.00K | GBX- | GBX1.04 Million | ▲ +19.5 pp |
| 2013 | 39.6% | GBX1.37 Million | GBX1.37 Million | GBX- | GBX3.45 Million | ▼ -6.8 pp |
| 2012 | 46.4% | GBX1.67 Million | GBX1.67 Million | GBX- | GBX3.60 Million | ▼ -15.1 pp |
| 2011 | 61.5% | GBX2.15 Million | GBX2.15 Million | GBX- | GBX3.49 Million | ▲ +20.1 pp |
| 2010 | 41.4% | GBX1.22 Million | GBX1.22 Million | GBX- | GBX2.96 Million | ▼ -3.2 pp |
| 2009 | 44.6% | GBX1.17 Million | GBX1.17 Million | GBX- | GBX2.63 Million | ▲ +1.1 pp |
| 2008 | 43.5% | GBX621.00K | GBX621.00K | GBX- | GBX1.43 Million | ▲ +33.2 pp |
| 2007 | 10.3% | GBX120.00K | GBX120.00K | GBX- | GBX1.17 Million | ▼ -3.8 pp |
| 2006 | 14.1% | GBX127.00K | GBX127.00K | GBX- | GBX903.00K | ▼ -992.9 pp |
| 2005 | 1007.0% | GBX3.91 Million | GBX3.91 Million | GBX- | GBX388.00K | ▲ +514.0 pp |
| 2004 | 492.9% | GBX4.12 Million | GBX4.12 Million | GBX- | GBX836.00K | — |